Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2000

Demichelis F, Berloffa F, Eccher C, Larcher B, Galvagni M, Sboner A, et al. Design and initial implementation of a regional tele-oncology project. J Telemed Telecare. 2000;6 Suppl 1:S71-3.

Jang BC, Sanchez T, Schaefers HJ, Trifan OC, Liu CH, Creminon C, et al. Serum withdrawal-induced post-transcriptional stabilization of cyclooxygenase-2 mRNA in MDA-MB-231 mammary carcinoma cells requires the activity of the p38 stress-activated protein kinase. J Biol Chem. 2000;275(50):39507-15.

Loda M, Xu X, Pession A, Vortmeyer A, Giangaspero F. Membranous expression of glucose transporter-1 protein (GLUT-1) in embryonal neoplasms of the central nervous system. Neuropathol Appl Neurobiol. 2000;26(1):91-7.

Saqi A, Osborne MP, Rosenblatt R, Shin SJ, Hoda SA. Quantifying mammary duct carcinoma in situ: a wild-goose chase? Am J Clin Pathol. 2000;113(5 Suppl 1):S30-7.

Chilosi M, Chiarle R, Lestani M, Menestrina F, Montagna L, Ambrosetti A, et al. Low expression of p27 and low proliferation index do not correlate in hairy cell leukaemia. Br J Haematol. 2000;111(1):263-71.

Crowson AN, Magro CM, Dawood MR. A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes. J Cutan Pathol. 2000;27(10):505-15.

Do RK, Hatada E, Lee H, Tourigny MR, Hilbert D, Chen-Kiang S. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med. 2000;192(7):953-64.

Prasad ML, Osborne MP, Giri DD, Hoda SA. Microinvasive carcinoma (T1mic) of the breast: clinicopathologic profile of 21 cases. Am J Surg Pathol. 2000;24(3):422-8.

Signoretti S, Montironi R, Manola J, Altimari A, Tam C, Bubley G, et al. Her-2-neu expression and progression toward androgen independence in human prostate cancer. J Natl Cancer Inst. 2000;92(23):1918-25.

Rand JH. The annexinopathies: a new category of diseases. Biochim Biophys Acta. 2000;1498(2-3):169-73.